Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)

Winthrop U Hospital, Mineola

University of Pittsburgh, Pittsburgh

Thomas Jefferson University Hospital, Philadelphia

Radiant Research, Wyomissing

Osteoporosis Clinical Trial Center, Hagerstown

McGuire Veterans Affairs Medical Center, Richmond

VA Commonwealth University, Richmond

United Osteoporosis Centers (UOC), Gainesville

CRIA Research, Fort Lauderdale

Comprehensive Clinical Trials, LLC, West Palm Beach

Radiant Research, Stuart

University of Tennessee Health Science, Memphis

University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati

School of Medicine, Indianapolis

Medical Specialist Clinical Research Center, Munster

Odyssey Research Services/CCRC Internal Medical, Fargo

Northwestern University Center for Clinical Research, Chicago

Washington University Center for Clinical Studies, St Louis

Heartland Research Associates, LLC, Wichita

University of Arkansas for Medical Science, Little Rock

Colorado Center for Bone Research, Lakewood

Southern Arizona VA, Tucson

New Mexico Clinical Research and Osteoporosis Center Inc, Albuquerque

Osteoporosis Medical Center, Beverly Hills

Osteoporosis Prevention Center, San Diego

Diablo Clinical Research, Inc, Walnut Creek

Puget Sound Osteoporosis Center, Seattle

Maine Center for Osteoporosis Research and Education, Bangor

Clinical Pharmacology Study Groups, Worcester

Rhode Island Hospital, Endocrinology Clinical Research Unit, Providence

Novartis, Nuremberg